Connection

Oliver Cornely to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Oliver Cornely has written about Antibodies, Monoclonal.
Oliver Cornely
Connection Strength
0.087
Antibodies, Monoclonal
  1. Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection. Clin Infect Dis. 2017 10 01; 65(7):1218-1221.
    View in: PubMed
    Score: 0.044
  2. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 01 26; 376(4):305-317.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.